Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants

Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants

Dabigatran etexilate (DE), rivaroxaban, and apixaban are nonvitamin K antagonist oral anticoagulants (NOACs) that have been compared in clinical trials with existing anticoagulants (warfarin and enoxaparin) in several indications for the prevention and treatment of thrombotic events. All NOACs prese...

Full description

Bibliographic Details
Main Authors:	Lessire Sarah, Dincq Anne-Sophie, Douxfils Jonathan, Devalet Bérangère, Nicolas Jean-Baptiste, Spinewine Anne, Larock Anne-Sophie, Dogné Jean-Michel, Gourdin Maximilien, Mullier François
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2014/616405

Similar Items

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”
by: Sarah Lessire, et al.
Published: (2014-01-01)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
by: Anne-Sophie Dincq, et al.
Published: (2014-01-01)

MINIMISATION OF BLEEDING RISKS DUE TO DIRECT ORAL ANTICOAGULANTS
by: Ovidiu Vornicu, et al.
Published: (2016-07-01)

Perioperative management of patients on direct oral anticoagulants
by: Virginie Dubois, et al.
Published: (2017-05-01)

Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations
by: Jonathan Douxfils, et al.
Published: (2015-01-01)

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
by: Anne-Laure Sennesael, et al.
Published: (2018-11-01)

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
by: Yoshinari Morimoto, et al.
Published: (2016-03-01)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
by: Blann A
Published: (2015-08-01)

Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants
by: Kyohei Maruyama, et al.
Published: (2018-01-01)

Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?
by: Jong S. Kim
Published: (2019-09-01)

Female Sex as a Thromboembolic Risk Factor in the Era of Nonvitamin K Antagonist Oral Anticoagulants
by: Mariacarla Gallù, et al.
Published: (2020-01-01)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)

The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review
by: Bérangère Devalet, et al.
Published: (2014-03-01)

Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment
by: Thomas Wilke, et al.
Published: (2019-01-01)

The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation
by: Thoranis Chantrarat, et al.
Published: (2021-08-01)

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
by: Julien Favresse, et al.
Published: (2018-04-01)

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
by: Sola Han, et al.
Published: (2021-08-01)

Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis
by: Caroline Dahlqvist, et al.
Published: (2016-01-01)

Corrigendum to “Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis”
by: Caroline Dahlqvist, et al.
Published: (2018-01-01)

The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants
by: Jamshed Dalal, et al.
Published: (2015-12-01)

Reduction of Preoperative Waiting Time Before Urgent Surgery for Patients on P2Y<sub>12</sub> Inhibitors Using Multiple Electrode Aggregometry: A Retrospective Study
by: Michaël Hardy, et al.
Published: (2020-02-01)

Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
by: Hélène Haguet, et al.
Published: (2020-05-01)

Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients
by: Jonathan Douxfils, et al.
Published: (2021-05-01)

Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS score ⩾ 2
by: Maria M Fernandez, et al.
Published: (2015-11-01)

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
by: Hélène Haguet, et al.
Published: (2018-01-01)

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
by: Constant Gillot, et al.
Published: (2021-08-01)

Effects of Time-Interval since Blood Draw and of Anticoagulation on Platelet Testing (Count, Indices and Impedance Aggregometry): A Systematic Study with Blood from Healthy Volunteers
by: Michael Hardy, et al.
Published: (2020-08-01)

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study
by: Hélène Haguet, et al.
Published: (2020-07-01)

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
by: Larisa Anghel, et al.
Published: (2020-05-01)

Anticoagulants and Gastrointestinal Bleeding
by: Mark Crowther, et al.
Published: (2005-01-01)

Risk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-Analysis.
by: Joel Skaistis, et al.
Published: (2015-01-01)

Prevalence of nonvitamin, nonmineral supplement usage among students in a Turkish university
by: Son Osman, et al.
Published: (2005-05-01)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
by: Helen Mani, et al.
Published: (2015-01-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

Understanding Bleeding Risk after Anticoagulation.
Published: (2005-10-01)

Bleeding issues in women prescribed anticoagulation
by: V. Speed, et al.
Published: (2021-12-01)

Characteristics, Location, and Clinical Outcomes of Gastrointestinal Bleeding in Patients Taking New Oral Anticoagulants Compared to Vitamin K Antagonists
by: A Reum Choe, et al.
Published: (2021-06-01)

Nonvitamin, Nonmineral Dietary Supplement Use among Adults with Fibromyalgia: United States, 2007–2012
by: Termeh Feinberg, et al.
Published: (2017-01-01)

Jet Ventilation during Rigid Bronchoscopy in Adults: A Focused Review
by: Laurie Putz, et al.
Published: (2016-01-01)

The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
by: Kuang-Tsu Yang, et al.
Published: (2021-12-01)